Auto-Immune Rare Disease Fund Inc (EIN 874578704) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2022

Legal Domicile

Phone

6175109274

Tax Period

2025-01-01 to 2025-12-31

Auto-Immune Rare Disease Fund Inc, founded in 2022, is a micro nonprofit in the Diseases & Disorders sector that reported $75 in total revenue in fiscal year 2025. Revenue fell 93% from the prior year — a significant decline worth monitoring. Expenses of $9K exceeded revenue, resulting in a 11261% operating deficit.

Mission

AUTO-IMMUNE RARE DISEASE FUND, INC AIRDF IS A NON-PROFIT ORGANIZATION COMMITTED TO FUNDING THE SECURING OF TREATMENTS AND THERAPIES FOR THOSE AFFLICTED WITH RARE AND OFTEN OVERLOOKED AUTO-IMMUNE DISEASES. AIRDF WILL WORK WITH EXTANT RESEARCH PROGRAMS, CLINICS AND LABS, AND MAKE APPROPRIATE GRANTS TO FIND PROMISING THERAPIES.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2025)

Revenue Breakdown

Contributions & Grants $75

Program Service Revenue $0

Investment Income $0

Other Revenue $0

TOTAL REVENUE $75

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Other Expenses $8,521

TOTAL EXPENSES $8,521

Year-over-Year Comparison

	2025	2024	Change
Revenue	$75	$1,043	-0.9%
Expenses	$8,521	$635	+12.4%
Net Income	$-8,446	$408	-21.7%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Jianshu Dong	Treasurer	1.00	Director	$0	$0	$0
Miru Shim	Director	1.00	Director	$0	$0	$0
Jonathan Badal	President	1.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$75	$8,521	$2,775,248	$-8,446
2024	No data	No data	No data	No data
2023	$14,201	$90	$2,793,820	$14,111
2022	$2,779,739	$30	$2,779,709	$2,779,709

Auto-Immune Rare Disease Fund Inc